|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/22 | (2006.01) |
| C12N 15/63 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3309248 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17183472.4 |
| Europos patento paraiškos padavimo data | 2014-04-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201370297 | 2013-05-29 | DK | |
| 201361888259 P | 2013-10-08 | US | |
| 201361907858 P | 2013-11-22 | US | |
| 201361907874 P | 2013-11-22 | US | |
| 201370771 | 2013-12-13 | DK | |
| PCT/EP2014/051458 | 2014-01-24 | WO |
| (72) |
DUCHATEAU, Philippe , FR
CHOULIKA, André , FR
POIROT, Laurent , FR
|
| (73) |
Cellectis ,
8 rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM |
| METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUIDED CAS NUCLEASE SYSTEM |